Sodium nitrite-sodium thiosulfate combination therapyAlternative Names: NDC 60267-812-00; Nithiodote; Sodium thiosulfate-sodium nitrite
Latest Information Update: 10 Aug 2011
At a glance
- Originator Hope Pharmaceuticals
- Class Antidotes; Nitrites; Nitrogen compounds; Sodium compounds; Thiosulfates; Vasodilators
- Mechanism of Action Antioxidants; Cytochrome modulators; Haemoglobin modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Poisoning
Most Recent Events
- 08 Aug 2011 Launched for Acute cyanide poisoning in USA (IV)